Travere Therapeutics
TVTX
TVTX
278 hedge funds and large institutions have $3.9B invested in Travere Therapeutics in 2025 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 90 increasing their positions, 93 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.18% more ownership
Funds ownership: 113.03% → 114.22% (+1.2%)
7% more call options, than puts
Call options by funds: $111M | Put options by funds: $103M
3% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 93
Holders
278
Holding in Top 10
8
Calls
$111M
Puts
$103M
Top Buyers
| 1 | +$219M | |
| 2 | +$50M | |
| 3 | +$28.4M | |
| 4 |
Goldman Sachs
New York
|
+$19.3M |
| 5 |
Renaissance Technologies
New York
|
+$16.1M |
Top Sellers
| 1 | -$119M | |
| 2 | -$96.3M | |
| 3 | -$27.5M | |
| 4 |
Jennison Associates
New York
|
-$26.9M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$23.3M |
